In breast cancer, HOXA1 was identified as a frequently methylated, and in an analysis similar to ours, was found to be significantly hypermethylated in atypical ductal hyperplasia (ADH) relative to normal breast, and ductal carcinoma in situ (DCIS) relative to ADH [50]. Here, HOXA1 is linked to atypical ductal hyperplasia.